Research programme: stem cell therapies - Harvard University/National Resilience
Latest Information Update: 27 Oct 2021
At a glance
- Originator Harvard University; National Resilience
- Class Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Musculoskeletal disorders